Rachel E. Jennings

Rachel E. Jennings

Auto-generated profile, based on publicly available information

Rachel E. Jennings

University of Manchester

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2015 in Development
Verified
Journal Article
Open access
PDF file
RJRachel E. Jennings
Rachel E. Jennings
ABAndrew A. Berry
Andrew A. Berry
JSJames P. Strutt
James P. Strutt
DGDavid T. Gerrard
David T. Gerrard
NHNeil A. Hanley
Neil A. Hanley
A wealth of data and comprehensive reviews exist on pancreas development in mammals, primarily mice, and other vertebrates. By contrast, human pancreatic development has been less comprehensively reviewed. Here, we draw together those studies conducted directly in human embryonic and fetal tissue to provide an overview of what is known about human pancreatic development. We discuss the relevance of this work to manufacturing insulin-secreting β-cells from pluripotent stem cells and to different aspects of diabetes, especially permanent neonatal diabetes, and its underlying causes.

17 September 2013 in Diabetes
Verified
Journal Article
Open access
RJRachel E. Jennings
Rachel E. Jennings
ABAndrew A. Berry
Andrew A. Berry
RKRebecca Kirkwood-Wilson
Rebecca Kirkwood-Wilson
NRNeil A. Roberts
Neil A. Roberts
THThomas Hearn
Thomas Hearn
NHNeil A. Hanley
Neil A. Hanley
Knowledge of human pancreas development underpins our interpretation and exploitation of human pluripotent stem cell (PSC) differentiation toward a β-cell fate. However, almost no information exists on the early events of human pancreatic specification in the distal foregut, bud formation, and early development. Here, we have studied the expression profiles of key lineage-specific markers to understand differentiation and morphogenetic events during human pancreas development. The notochord was adjacent to the dorsal foregut endoderm during the fourth week of development before pancreatic duodenal homeobox-1 detection. In contrast to the published data from mouse embryos, during human pancreas development, we detected only a single-phase of Neurogenin 3 (NEUROG3) expression and endocrine differentiation from approximately 8 weeks, before which Nirenberg and Kim homeobox 2.2 (NKX2.2) was not observed in the pancreatic progenitor cell population. In addition to revealing a number of disparities in timing between human and mouse development, these data, directly assembled from human tissue, allow combinations of transcription factors to define sequential stages and differentiating pancreatic cell types. The data are anticipated to provide a useful reference point for stem cell researchers looking to differentiate human PSCs in vitro toward the pancreatic β-cell so as to model human development or enable drug discovery and potential cell therapy.

27 April 2015 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
ICInês Cebola
Inês Cebola
SRSantiago A. Rodríguez-Seguí
Santiago A. Rodríguez-Seguí
CCCandy H-H. Cho
Candy H-H. Cho
JBJose Bessa
Jose Bessa
MRMeritxell Rovira
Meritxell Rovira
JFJorge Ferrer
Jorge Ferrer
The genomic regulatory programmes that underlie human organogenesis are poorly understood. Pancreas development, in particular, has pivotal implications for pancreatic regeneration, cancer and diabetes. We have now characterized the regulatory landscape of embryonic multipotent progenitor cells that give rise to all pancreatic epithelial lineages. Using human embryonic pancreas and embryonic-stem-cell-derived progenitors we identify stage-specific transcripts and associated enhancers, many of which are co-occupied by transcription factors that are essential for pancreas development. We further show that TEAD1, a Hippo signalling effector, is an integral component of the transcription factor combinatorial code of pancreatic progenitor enhancers. TEAD and its coactivator YAP activate key pancreatic signalling mediators and transcription factors, and regulate the expansion of pancreatic progenitors. This work therefore uncovers a central role for TEAD and YAP as signal-responsive regulators of multipotent pancreatic progenitors, and provides a resource for the study of embryonic development of the human pancreas.

1 March 2010 in Hormone Research in Paediatrics
Verified
Journal Article
Open access
PDF file
IKIlonka Kreitschmann-Andermahr
Ilonka Kreitschmann-Andermahr
PSPablo Suarez
Pablo Suarez
RJRachel Jennings
Rachel Jennings
NENina Evers
Nina Evers
GBGeorg Brabant
Georg Brabant
Growth hormone (GH) secretion in children and adults is profoundly, but reversibly, suppressed in obesity. Since GH deficiency leads to increased fat mass, differentiation of both conditions remains challenging. Here we review the known and still speculative mechanisms underlying the inhibitory effects of obesity on GH secretion including peripheral factors like IGF-I and insulin, as well as central hypothalamic/pituitary modulators. We further discuss the basis of current testing for GH deficiency in obesity and the validity of the various provocative tests in overweight subjects.

4 May 2014 in Islets
Verified
Journal Article
Open access
RSRachel J Salisbury
Rachel J Salisbury
JBJennifer Blaylock
Jennifer Blaylock
ABAndrew A Berry
Andrew A Berry
RJRachel E Jennings
Rachel E Jennings
RKRonald De Krijger
Ronald De Krijger
NHNeil A Hanley
Neil A Hanley
The basic helix-loop-helix transcription factor, NEUROG3, is critical in causing endocrine commitment from a progenitor cell population in the developing pancreas. In human, NEUROG3 has been detected from 8 weeks post-conception (wpc). However, the profile of its production and when it ceases to be detected is unknown. In this study we have defined the profile of NEUROG3 detection in the developing pancreas to give insight into when NEUROG3-dependent endocrine commitment is possible in the human fetus. Immunohistochemistry allowed counting of cells with positively stained nuclei from 7 wpc through to term. mRNA was also isolated from sections of human fetal pancreas and NEUROG3 transcription analyzed by quantitative reverse transcription and polymerase chain reaction. NEUROG3 was detected as expected at 8 wpc. The number of NEUROG3-positive cells increased to peak levels between 10 wpc and 14 wpc. It declined at and after 18 wpc such that it was not detected in human fetal pancreas at 35–41 wpc. Analysis ...

24 August 2016 in eLife
Verified
Journal Article
Open access
DGDave T Gerrard
Dave T Gerrard
ABAndrew A Berry
Andrew A Berry
RJRachel E Jennings
Rachel E Jennings
KHKaren Piper Hanley
Karen Piper Hanley
NBNicoletta Bobola
Nicoletta Bobola
NHNeil A Hanley
Neil A Hanley
Human organogenesis is when severe developmental abnormalities commonly originate. However, understanding this critical embryonic phase has relied upon inference from patient phenotypes and assumptions from in vitro stem cell models and non-human vertebrates. We report an integrated transcriptomic atlas of human organogenesis. By lineage-guided principal components analysis, we uncover novel relatedness of particular developmental genes across different organs and tissues and identified unique transcriptional codes which correctly predicted the cause of many congenital disorders. By inference, our model pinpoints co-enriched genes as new causes of developmental disorders such as cleft palate and congenital heart disease. The data revealed more than 6000 novel transcripts, over 90% of which fulfil criteria as long non-coding RNAs correlated with the protein-coding genome over megabase distances. Taken together, we have uncovered cryptic transcriptional programs used by the human embryo and established a new resource for the molecular understanding of human organogenesis and its associated disorders.